gastrointestinal stromal tumor
Conditions
Brief summary
Recurrence-free survival (RFS). Defined by the time interval between the date of randomisation and the date of first detection of GIST recurrence or death, whichever occurs first. CT/MRI at 6-month intervals during the first 5 years on study in each arm, and then annually.
Detailed description
Overall survival., GIST-specific survival. The time period between the date of randomisation and the date of death considered to be caused by GIST; patients who die from other causes are censored on the date of death., Safety., Quality of Life
Interventions
Sponsors
Region Skane
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence-free survival (RFS). Defined by the time interval between the date of randomisation and the date of first detection of GIST recurrence or death, whichever occurs first. CT/MRI at 6-month intervals during the first 5 years on study in each arm, and then annually. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival., GIST-specific survival. The time period between the date of randomisation and the date of death considered to be caused by GIST; patients who die from other causes are censored on the date of death., Safety., Quality of Life | — |
Countries
Austria, Denmark, Finland, Germany, Netherlands, Norway, Spain, Sweden
Outcome results
None listed